搜索





搜索





市场行情
/
股票
/
atra
/

Atara Biotherapeutics Inc

ATRA

添加自选

8.380USD

+0.210+2.57%

收盘 07-31 16:00（美东）报价延迟15分钟

60.42M总市值

亏损市盈率 TTM

Atara Biotherapeutics Inc

8.380

+0.210+2.57%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

ATRA 利润表

您可以在这里找到Atara Biotherapeutics Inc的年度或季度收入报告，以深入了解Atara Biotherapeutics Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q4

FY2014Q3

FY2014Q2

FY2014Q1

FY2013Q2

FY2013Q1

营业总收入

-99.47%516.00K

-95.13%1.59M

-91.41%3.45M

-38.63%17.57M

258.77%98.15M

670.30%32.75M

1779.79%40.19M

2892.69%28.64M

2131.40%27.36M

1823.98%4.25M

-52.05%2.14M

-98.14%957.00K

-83.24%1.23M

-97.07%221.00K

-16.96%4.46M

1232.79%51.58M

105.91%7.31M

--7.55M

--5.37M

--3.87M

--3.55M

----

--0.00

----

--0.00

营业收入

-99.47%516.00K

-95.13%1.59M

-91.41%3.45M

-38.63%17.57M

258.77%98.15M

670.30%32.75M

1779.79%40.19M

2892.69%28.64M

2131.40%27.36M

1823.98%4.25M

-52.05%2.14M

-98.14%957.00K

-83.24%1.23M

-97.07%221.00K

-16.96%4.46M

1232.79%51.58M

105.91%7.31M

--7.55M

--5.37M

--3.87M

--3.55M

----

--0.00

主营业务成本

-99.39%124.00K

-98.47%104.00K

-98.49%115.00K

-88.03%554.00K

929.67%20.44M

115.03%6.79M

190.71%7.60M

59.83%4.63M

818.98%1.98M

--3.16M

--2.62M

--2.90M

--216.00K

----

营业费用

-91.45%3.88M

-93.52%2.91M

-88.70%7.00M

-72.36%12.86M

-15.63%45.43M

-21.86%44.96M

-13.66%61.95M

-35.73%46.52M

-29.33%53.85M

-23.99%57.53M

-13.75%71.75M

-13.55%72.37M

-20.24%76.20M

-25.03%75.69M

-7.75%83.19M

-4.74%83.71M

16.79%95.53M

23.57%100.95M

20.72%90.18M

12.73%87.87M

9.51%81.80M

2.51%81.70M

2.96%74.71M

3.20%77.95M

10.02%74.70M

-2.59%79.70M

20.48%72.56M

43.54%75.53M

59.92%67.89M

128.52%81.82M

90.21%60.22M

88.55%52.62M

62.27%42.45M

90.90%35.80M

22.04%31.66M

43.23%27.91M

53.34%26.16M

-13.85%18.75M

111.62%25.94M

28.97%19.48M

83.23%17.06M

105.45%21.77M

106.07%12.26M

233.22%15.11M

31.57%9.31M

--10.60M

--5.95M

233.14%4.53M

450.31%7.08M

--1.36M

--1.29M

研发费用

-98.91%164.00K

-99.36%185.00K

-93.37%2.91M

-80.70%6.37M

-64.42%14.98M

-34.70%28.72M

-22.79%43.92M

-41.26%32.98M

-32.25%42.11M

-29.83%43.98M

-15.66%56.89M

-13.49%56.14M

-17.08%62.16M

-20.79%62.68M

-4.10%67.45M

-5.22%64.90M

17.02%74.96M

20.72%79.13M

17.46%70.33M

11.23%68.47M

11.10%64.06M

6.35%65.55M

11.84%59.88M

17.82%61.56M

18.47%57.66M

-0.99%61.64M

23.49%53.54M

56.50%52.25M

71.00%48.67M

151.32%62.26M

110.48%43.35M

82.48%33.39M

62.25%28.46M

83.84%24.77M

9.55%20.60M

40.84%18.30M

55.96%17.54M

-16.99%13.47M

131.75%18.80M

12.90%12.99M

95.02%11.25M

221.53%16.23M

91.30%8.11M

262.31%11.51M

93.46%5.77M

--5.05M

--4.24M

458.17%3.18M

742.09%2.98M

--569.00K

--354.00K

折旧摊销及损耗

-98.38%29.00K

-90.91%100.00K

-97.07%36.00K

-82.26%236.00K

29.04%1.79M

-8.71%1.10M

1.74%1.23M

10.74%1.33M

14.58%1.39M

-7.31%1.21M

-13.64%1.21M

-16.48%1.20M

-23.70%1.21M

-50.83%1.30M

-40.68%1.40M

-37.96%1.44M

-28.40%1.59M

22.58%2.64M

7.27%2.36M

10.38%2.32M

16.95%2.22M

9.27%2.16M

16.83%2.20M

11.46%2.10M

15.29%1.90M

33.56%1.97M

58.24%1.88M

157.73%1.88M

394.89%1.65M

431.65%1.48M

376.00%1.19M

229.28%731.00K

61.65%333.00K

60.69%278.00K

90.84%250.00K

246.88%222.00K

1273.33%206.00K

540.74%173.00K

1210.00%131.00K

1180.00%64.00K

150.00%15.00K

1250.00%27.00K

400.00%10.00K

305.19%5.00K

438.12%6.00K

--2.00K

23.40%1.23K

11.50%1.11K

--1.00K

其他营业费用

----

---745.00K

----

营业利润

-106.39%-3.37M

89.21%-1.32M

83.70%-3.55M

126.41%4.72M

298.95%52.72M

77.10%-12.20M

68.75%-21.76M

74.97%-17.88M

64.66%-26.50M

29.40%-53.28M

11.58%-69.61M

-122.25%-71.41M

15.02%-74.97M

19.20%-75.47M

7.17%-78.73M

61.75%-32.13M

-12.75%-88.22M

-14.33%-93.40M

-13.53%-84.81M

-7.76%-84.00M

-4.75%-78.25M

-2.51%-81.70M

-2.96%-74.71M

-3.20%-77.95M

-10.02%-74.70M

2.59%-79.70M

-20.48%-72.56M

-43.54%-75.53M

-59.92%-67.89M

-128.52%-81.82M

-90.21%-60.22M

-88.55%-52.62M

-62.27%-42.45M

-90.90%-35.80M

-22.04%-31.66M

-43.23%-27.91M

-53.34%-26.16M

13.85%-18.75M

-111.62%-25.94M

-28.97%-19.48M

-83.23%-17.06M

-105.45%-21.77M

-106.07%-12.26M

-233.22%-15.11M

-31.57%-9.31M

---10.60M

---5.95M

-233.14%-4.53M

-450.31%-7.08M

---1.36M

---1.29M

净非营业利息收入（费用）

利息收入

-77.12%54.00K

-83.25%100.00K

-55.56%204.00K

-68.22%143.00K

-60.93%236.00K

-16.03%597.00K

-62.32%459.00K

-73.45%450.00K

-66.48%604.00K

-26.63%711.00K

125.14%1.22M

369.53%1.69M

1466.96%1.80M

1053.57%969.00K

265.54%541.00K

60.44%361.00K

--115.00K

-78.89%84.00K

-59.34%148.00K

-54.73%225.00K

----

-67.24%398.00K

-44.93%364.00K

-58.82%497.00K

-27.29%1.19M

-30.85%1.22M

-64.44%661.00K

-30.75%1.21M

61.94%1.63M

271.46%1.76M

229.61%1.86M

262.37%1.74M

98.23%1.01M

-8.86%473.00K

-2.08%564.00K

-20.50%481.00K

1.19%509.00K

-0.57%519.00K

51.58%576.00K

271.17%605.00K

228.76%503.00K

690.91%522.00K

1166.67%380.00K

608.70%163.00K

2450.00%153.00K

--66.00K

--30.00K

475.00%23.00K

200.00%6.00K

--4.00K

--2.00K

利息费用

-18.39%830.00K

-12.09%894.00K

-23.16%909.00K

-22.98%972.00K

-11.80%1.02M

-13.52%1.02M

1905.08%1.18M

901.59%1.26M

773.48%1.15M

--1.18M

--59.00K

--126.00K

--132.00K

----

出售证券收益

----

---1.34M

---1.25M

---1.20M

----

特殊收入（费用）

----

---1.25M

---27.00K

-327.81%-1.52M

-192.84%-13.91M

100.00%0.00

--0.00

---356.00K

-10457.78%-4.75M

-8933.78%-6.69M

100.00%0.00

--0.00

---45.00K

---74.00K

---5.89M

----

--0.00

----

--0.00

-固定资产出售收益

----

--0.00

-100.00%0.00

----

--0.00

--50.24M

----

其他非经营性收入（费用）

100.00%0.00

44.94%-49.00K

-99.28%4.00K

466.67%22.00K

-116.18%-11.00K

-641.67%-89.00K

2155.56%555.00K

40.00%-6.00K

134.52%68.00K

---12.00K

---27.00K

---10.00K

---197.00K

----

税前利润

-110.91%-4.14M

73.21%-3.41M

80.50%-4.28M

112.55%2.39M

219.80%38.01M

78.97%-12.71M

68.59%-21.93M

73.21%-19.05M

57.55%-31.73M

18.95%-60.44M

16.97%-69.82M

-485.07%-71.11M

15.16%-74.75M

20.09%-74.57M

0.69%-84.08M

122.04%18.47M

-12.47%-88.11M

-14.78%-93.32M

-13.88%-84.66M

-8.16%-83.78M

-6.57%-78.33M

-3.59%-81.30M

-3.40%-74.34M

-4.21%-77.45M

-10.95%-73.51M

1.97%-78.48M

-23.19%-71.89M

-46.08%-74.33M

-59.88%-66.26M

-126.61%-80.06M

-87.68%-58.36M

-85.50%-50.88M

-61.56%-41.44M

-93.74%-35.33M

-22.59%-31.10M

-45.28%-27.43M

-54.92%-25.65M

14.18%-18.23M

-113.54%-25.37M

-26.33%-18.88M

-80.80%-16.56M

-101.79%-21.25M

-100.69%-11.88M

-231.30%-14.95M

-29.51%-9.16M

---10.53M

---5.92M

-232.42%-4.51M

-450.70%-7.07M

---1.36M

---1.28M

所得税

--0.00

100.00%0.00

264.71%28.00K

--3.00K

-100.00%0.00

-272.73%-19.00K

10.53%-17.00K

-100.00%0.00

9.09%24.00K

450.00%11.00K

-290.00%-19.00K

--1.00K

--22.00K

-93.33%2.00K

--10.00K

-100.00%0.00

--0.00

275.00%30.00K

-100.00%0.00

1500.00%16.00K

----

-33.33%8.00K

--6.00K

--1.00K

----

125.53%12.00K

--0.00

-100.00%0.00

----

-193.75%-47.00K

--0.00

--3.00K

-100.00%0.00

---16.00K

-100.00%0.00

--0.00

-33.33%2.00K

--0.00

163.64%7.00K

--0.00

50.00%3.00K

100.00%0.00

---11.00K

--0.00

109.09%2.00K

---3.00K

--0.00

-100.00%0.00

-257.14%-22.00K

--26.00K

--14.00K

除税后利润

-110.91%-4.14M

73.17%-3.41M

80.36%-4.30M

112.53%2.39M

219.71%38.01M

79.00%-12.69M

68.61%-21.91M

73.21%-19.05M

57.53%-31.75M

18.94%-60.45M

17.00%-69.80M

-485.08%-71.11M

15.13%-74.77M

20.11%-74.57M

0.68%-84.09M

122.04%18.47M

-12.47%-88.11M

-14.81%-93.35M

-13.88%-84.66M

-8.18%-83.79M

-6.57%-78.33M

-3.58%-81.31M

-3.41%-74.35M

-4.21%-77.46M

-10.95%-73.51M

1.89%-78.50M

-23.19%-71.89M

-46.08%-74.33M

-59.88%-66.26M

-126.58%-80.01M

-87.68%-58.36M

-85.51%-50.88M

-61.55%-41.44M

-93.66%-35.31M

-22.56%-31.10M

-45.28%-27.43M

-54.91%-25.65M

14.18%-18.23M

-113.79%-25.37M

-26.33%-18.88M

-80.80%-16.56M

-101.84%-21.25M

-100.51%-11.87M

-231.30%-14.95M

-29.95%-9.16M

---10.53M

---5.92M

-226.17%-4.51M

-443.07%-7.05M

---1.38M

---1.30M

持续经营利润

-110.91%-4.14M

73.17%-3.41M

80.36%-4.30M

112.53%2.39M

219.71%38.01M

79.00%-12.69M

68.61%-21.91M

73.21%-19.05M

57.53%-31.75M

18.94%-60.45M

17.00%-69.80M

-485.08%-71.11M

15.13%-74.77M

20.11%-74.57M

0.68%-84.09M

122.04%18.47M

-12.47%-88.11M

-14.81%-93.35M

-13.88%-84.66M

-8.18%-83.79M

-6.57%-78.33M

-3.58%-81.31M

-3.41%-74.35M

-4.21%-77.46M

-10.95%-73.51M

1.89%-78.50M

-23.19%-71.89M

-46.08%-74.33M

-59.88%-66.26M

-126.58%-80.01M

-87.68%-58.36M

-85.51%-50.88M

-61.55%-41.44M

-93.66%-35.31M

-22.56%-31.10M

-45.28%-27.43M

-54.91%-25.65M

14.18%-18.23M

-113.79%-25.37M

-26.33%-18.88M

-80.80%-16.56M

-101.84%-21.25M

-100.51%-11.87M

-231.30%-14.95M

-29.95%-9.16M

---10.53M

---5.92M

-226.17%-4.51M

-443.07%-7.05M

---1.38M

---1.30M

归属于母公司的净利润

-110.91%-4.14M

73.17%-3.41M

80.36%-4.30M

112.53%2.39M

219.71%38.01M

79.00%-12.69M

68.61%-21.91M

73.21%-19.05M

57.53%-31.75M

18.94%-60.45M

17.00%-69.80M

-485.08%-71.11M

15.13%-74.77M

20.11%-74.57M

0.68%-84.09M

122.04%18.47M

-12.47%-88.11M

-14.81%-93.35M

-13.88%-84.66M

-8.18%-83.79M

-6.57%-78.33M

-3.58%-81.31M

-3.41%-74.35M

-4.21%-77.46M

-10.95%-73.51M

1.89%-78.50M

-23.19%-71.89M

-46.08%-74.33M

-59.88%-66.26M

-126.58%-80.01M

-87.68%-58.36M

-85.51%-50.88M

-61.55%-41.44M

-93.66%-35.31M

-22.56%-31.10M

-45.28%-27.43M

-54.91%-25.65M

14.18%-18.23M

-113.79%-25.37M

-26.33%-18.88M

-80.80%-16.56M

-101.84%-21.25M

-100.51%-11.87M

-231.30%-14.95M

-29.95%-9.16M

---10.53M

---5.92M

-226.17%-4.51M

-443.07%-7.05M

---1.38M

---1.30M

归属于普通股东的净利润

-110.91%-4.14M

73.17%-3.41M

80.36%-4.30M

112.53%2.39M

219.71%38.01M

79.00%-12.69M

68.61%-21.91M

73.21%-19.05M

57.53%-31.75M

18.94%-60.45M

17.00%-69.80M

-485.08%-71.11M

15.13%-74.77M

20.11%-74.57M

0.68%-84.09M

122.04%18.47M

-12.47%-88.11M

-14.81%-93.35M

-13.88%-84.66M

-8.18%-83.79M

-6.57%-78.33M

-3.58%-81.31M

-3.41%-74.35M

-4.21%-77.46M

-10.95%-73.51M

1.89%-78.50M

-23.19%-71.89M

-46.08%-74.33M

-59.88%-66.26M

-126.58%-80.01M

-87.68%-58.36M

-85.51%-50.88M

-61.55%-41.44M

-93.66%-35.31M

-22.56%-31.10M

-45.28%-27.43M

-54.91%-25.65M

14.18%-18.23M

-113.79%-25.37M

-26.33%-18.88M

-80.80%-16.56M

-101.84%-21.25M

-100.51%-11.87M

-231.30%-14.95M

-29.95%-9.16M

---10.53M

---5.92M

-226.17%-4.51M

-443.07%-7.05M

---1.38M

---1.30M

基本每股收益

-108.34%-0.29

78.90%-0.25

89.19%-0.32

105.04%0.20

162.54%3.53

91.52%-1.19

82.11%-2.93

77.04%-3.88

68.60%-5.65

22.66%-13.97

20.10%-16.40

-472.29%-16.92

17.78%-17.98

24.56%-18.07

9.23%-20.53

119.99%4.54

-2.12%-21.87

-0.60%-23.95

1.24%-22.61

20.20%-22.73

28.68%-21.41

30.00%-23.81

30.04%-22.90

28.83%-28.49

16.40%-30.02

22.13%-34.01

-1.85%-32.73

-39.64%-40.02

-37.25%-35.91

-51.69%-43.67

-25.96%-32.13

-22.26%-28.66

-18.54%-26.17

-82.64%-28.79

-15.83%-25.51

-42.39%-23.45

-52.17%-22.07

15.57%-15.76

-105.43%-22.02

-6.76%-16.47

-38.84%-14.51

64.63%-18.67

-46.45%-10.72

-165.37%-15.42

-15.03%-10.45

---52.79

---7.32

-226.16%-5.81

-443.03%-9.08

---1.78

---1.67

稀释每股收益

-108.40%-0.29

78.90%-0.25

89.19%-0.32

104.99%0.19

162.04%3.50

91.52%-1.19

82.11%-2.93

77.04%-3.88

68.60%-5.65

22.66%-13.97

20.10%-16.40

-473.25%-16.92

17.78%-17.98

24.56%-18.07

9.23%-20.53

119.94%4.53

-2.12%-21.87

-0.60%-23.95

1.24%-22.61

20.20%-22.73

28.68%-21.41

30.00%-23.81

30.04%-22.90

28.83%-28.49

16.40%-30.02

22.13%-34.01

-1.85%-32.73

-39.64%-40.02

-37.25%-35.91

-51.69%-43.67

-25.96%-32.13

-22.26%-28.66

-18.54%-26.17

-82.64%-28.79

-15.83%-25.51

-42.39%-23.45

-52.17%-22.07

15.57%-15.76

-105.43%-22.02

-6.76%-16.47

-38.84%-14.51

64.63%-18.67

-46.45%-10.72

-165.37%-15.42

-15.03%-10.45

---52.79

---7.32

-226.16%-5.81

-443.03%-9.08

---1.78

---1.67

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Atara Biotherapeutics Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 ATRA 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Atara Biotherapeutics Inc 财年末的营收是多少？



Atara Biotherapeutics Inc 2025 财年营收为 120.77M，高于上一财年的128.94M。

Atara Biotherapeutics Inc 最近一个季度的营收是多少？



Atara Biotherapeutics Inc 最近一个季度的营收为 516.00K，同比增长 -99.47%。

Atara Biotherapeutics Inc 全年的净利润是多少？



Atara Biotherapeutics Inc 2025 财年净利润为 32.69M。

Atara Biotherapeutics Inc 上一季度的净利润是多少？



Atara Biotherapeutics Inc 最近一个季度的净利润为 -4.14M。

Atara Biotherapeutics Inc 年度营业利润是多少？



Atara Biotherapeutics Inc 2025 财年的营业利润为 52.57M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。